CCND1 and colorectal cancer: (130) found that T antigen and β-catenin were co-localized in the nuclei of colorectal cancer cells, resulting in the activation of TCF4-dependent promoters and the transcription of TCF4 downstream targets (e.g. c-myc, VEGF and Cyclin D1).